Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
RSV (Respiratory syncytial virus)
2023
2020
Americas
Clear all
Type of publications
NITAG documentation
(74)
Systematic reviews (SYSVAC)
(2)
Topics
Available to download in languages
Regions
Americas
(76)
Africa
(9)
Eastern Mediterranean
(2)
Europe
(35)
South-East Asia
(3)
Western Pacific
(24)
Countries
Argentina
(1)
Canada
(9)
Chile
(12)
United States of America
(53)
Diseases
COVID-19
(72)
RSV (Respiratory syncytial virus)
(5)
Dengue
(1)
Diphtheria
(1)
Hepatitis A
(1)
Hepatitis B
(1)
Herpes zoster
(1)
Human papillomavirus (HPV)
(5)
Influenza
(6)
Meningococcal disease
(3)
Pertussis
(1)
Pneumococcal disease
(5)
Poliomyelitis
(1)
Tetanus
(1)
Vaccine topics
Acceptance
(1)
Ethical issues
(1)
Target population
All age groups
(2)
Children
(1)
Healthcare workers
(2)
Older adults
(3)
Pregnant women
(1)
Risk group
(3)
Publication date
2023
(14)
2020
(62)
2024
(3)
2022
(39)
2021
(64)
2019
(1)
2018
(4)
2017
(1)
2015
(3)
2010
(2)
2008
(1)
2002
(2)
2001
(1)
76 results found
2023
∙
Martin, P. Martin, R. DeBritz, A. A. Kang, A. W.
COVID-19 vaccination in correctional systems in the United States
2023
∙
Xiao, Hong Vaidya, Riha Liu, Fang Chang, Ximing Xia, Xiaoqian Unger, Joseph M.
Sex, Racial, and Ethnic Representation in COVID-19 Clinical Trials: A Systematic Review and Meta-analysis
2023
∙
CAVEI
CAVEI recommendation on incorporation of a monoclonal antibody for passive immunization against respiratory syncytial virus in infants in the Program National Immunization
2023
∙
CAVEI
CAVEI RECOMMENDATION ON VACCINATION INCORPORATION AGAINST RESPIRATORY SYNCYCIAL VIRUS IN OLDER ADULTS AND PREGNANT WOMEN IN THE NATIONAL IMMUNIZATION PROGRAM
2023
∙
CAVEI
CAVEI recommendation on updating the vaccination strategy against COVID-19 by 2024
2023
∙
CoNaIn
CoNaIn 9th November 2023 meeting minutes
2023
∙
NACI
Updated guidance on the use of COVID-19 vaccines in individuals who have not previously been vaccinated against COVID-19
2023
∙
ACIP
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices
2023
∙
ACIP
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices
2023
∙
ACIP
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register